RCM Technologies, Inc. — Form 10-Q Summary
Period clarification: The filing covers the 13- and 39-week periods ended September 28, 2013, compared with periods ended September 29, 2012. This is a 2013 third-quarter filing, notwithstanding the request metadata’s “2012 Q3” label. Financial statement amounts below are in millions of dollars unless stated otherwise.
Business context and reporting period
RCM provides information technology, engineering, and specialty health care services, including consulting, project solutions, and staffing. The company describes its markets as cyclical and sensitive to economic conditions, client spending, competition, and availability of qualified personnel. Its fiscal quarters follow a 52/53-week calendar; both comparison periods were 13 weeks, and the year-to-date periods were 39 weeks.
Financial results and liquidity
| Metric | Q3 2013 | Q3 2012 | 39 weeks 2013 | 39 weeks 2012 |
|---|---|---|---|---|
| Revenue | $41.320 | $34.839 | $124.929 | $108.798 |
| Gross profit / gross margin | $10.684 / 25.9% | $9.675 / 27.8% | $32.567 / 26.1% | $29.616 / 27.2% |
| Operating income / margin | $1.806 / 4.4% | $1.107 / 3.2% | $5.034 / 4.0% | $3.897 / 3.6% |
| Net income | $1.142 | $0.634 | $3.572 | $2.197 |
| Diluted EPS | $0.09 | $0.05 | $0.29 | $0.17 |
| Operating cash flow | Not reported by quarter in the provided cash-flow statement | $0.740 | $7.448 |
Q3 revenue rose 18.6% year over year; year-to-date revenue rose 14.8%. Engineering was the main growth driver: year-to-date segment revenue increased 30.4% to $63.263 million. Information Technology revenue increased 4.7% to $41.378 million, while Specialty Health Care revenue declined 2.2% to $20.288 million. Q3 Specialty Health Care revenue rebounded 15.8% year over year.
Gross margin declined in both comparison periods, reflecting less higher-margin project work, higher non-billable labor in parts of Engineering, and increased Specialty Health Care service costs. SG&A as a percentage of revenue improved year to date, to 21.1% from 22.8%, helping lift operating margin despite the lower gross margin.
At September 28, 2013, cash was $14.049 million, total current assets were $75.980 million, and current liabilities were $26.554 million (working capital of approximately $49.426 million). Total assets were $89.956 million and stockholders’ equity was $62.785 million. The balance sheet reports no borrowings; the $15 million revolving facility had $14.2 million available after $0.8 million of letters of credit. The facility matures August 31, 2016 and is secured by company assets and subsidiary stock.
Cash declined $0.074 million over the 39 weeks, ending at $14.049 million, versus a $1.795 million increase in the prior-year period. Operating cash flow fell to $0.740 million from $7.448 million, chiefly as accounts receivable used $11.055 million of cash, compared with providing $0.891 million in the prior period. Capital expenditures were $1.071 million. Management said it expects the receivables-to-revenue ratio to improve over coming quarters.
Material changes and notable items
- Year-to-date Engineering growth included $9.7 million of increased Canadian Engineering revenue and $3.6 million attributable to the BGA acquisition. The acquisition contributed approximately $0.8 million of SG&A.
- A large fixed-price Engineering contract had costs exceeding estimates, contributing to higher service costs as a percentage of revenue.
- Specialty Health Care year-to-date operating income fell to $0.650 million from $0.985 million. Management cited lower revenue from two major clients, labor-supply tightness, and lower-margin geographic expansion.
- The company recorded a $0.343 million facilities-consolidation charge related mainly to severance and other costs for consolidating its Canadian Mississauga office into Pickering.
- Year-to-date income tax expense included a $0.5 million benefit from reducing an unrecognized tax benefit after a statute of limitations expired. The reported 39-week effective tax rate was 30.1%; management stated the rate before this discrete benefit was approximately 39.3%.
- Other income included a $0.092 million reduction in contingent consideration related to the 2009 Project Solutions Group acquisition. Estimated remaining BGA contingent payments totaled $1.142 million and are subject to performance estimates; cumulative payments are capped at $3.0 million.
Outlook, risks, and contingencies
Management said it was optimistic that results for the remaining quarter of fiscal 2013 should remain favorable; the filing provides no specific numerical earnings or revenue guidance. It anticipated working capital as the primary future capital use and believed resources were sufficient for obligations in the normal course for at least 12 months. It also anticipated potential increased spending in 2014 to enhance financial reporting and accounting systems.
Key risks include economic cyclicality and client spending, competition and pricing pressure, recruiting and retaining qualified staff, project execution and fixed-price contract costs, customer concentration, insurance and employment-related claims, acquisition integration and contingent payments, and access to financing. The company reported asserted legal claims seeking approximately $9.7 million in damages, with a recorded provision of approximately $0.1 million; it cautioned that some matters may not be insured and an unfavorable outcome could materially affect results, liquidity, or financial position.
The Board adopted a stockholder rights plan, amended in May 2013 to add a qualifying-offer redemption feature. The plan may dilute an unapproved acquirer reaching a 15% ownership threshold. Management also cited professional fees related primarily to a potential contested proxy fight. The company reported disclosure controls were effective and no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether the sharp year-to-date operating cash-flow decline and higher receivables are temporary; monitor collections and receivables relative to revenue.
- Whether revenue growth converts to sustainable margins, especially given lower gross margins, the fixed-price contract overrun, and Specialty Health Care labor costs and client concentration.
- The performance assumptions and timing for the remaining $1.142 million estimated BGA contingent consideration.
- Developments, insurance coverage, and potential exposure in legal matters with approximately $9.7 million of asserted damages versus the $0.1 million recorded provision.
- Potential costs and governance implications of the rights plan and any proxy contest, as well as the expected cost of the planned 2014 systems upgrade.
- The filing’s share-count figures differ: the cover page states 12,366,959 shares outstanding as of October 30, 2013, while the balance sheet reports 12,365,959 shares outstanding at September 28, 2013 and the cover-page context elsewhere may use a different date. Confirm the applicable outstanding-share count.